Funder: Bill and Melinda Gates Foundation
Due Dates: July 7, 2025, 11:30 AM Pacific Time (Full proposal deadline)
Funding Amounts: $8–10 million USD per award | Up to 48 months per project
Summary: Supports randomized controlled trials in sub-Saharan Africa to evaluate the impact of STI screening and treatment on reproductive tract sequelae in non-pregnant women.
Key Information: Proposals must include pelvic inflammatory disease (PID) as a primary outcome and trial sites must be in sub-Saharan Africa.